Alibaba Health Information Technology Limited (HKG: 0241)

Market Cap	55.96B
Revenue (ttm)	31.39B
Net Income (ttm)	1.34B
Shares Out	16.08B
EPS (ttm)	0.09
PE Ratio	39.99
Forward PE	26.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,471,904
Average Volume	37,217,743
Open	3.400
Previous Close	3.380
Day's Range	3.400 - 3.520
52-Week Range	2.590 - 6.300
Beta	1.10
RSI	55.19
Earnings Date	Feb 12, 2025

About Alibaba Health Information Technology

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, includi...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,435
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0241

Financial Performance

In 2023, Alibaba Health Information Technology's revenue was 27.03 billion, an increase of 0.98% compared to the previous year's 26.76 billion. Earnings were 883.48 million, an increase of 64.93%.

Financial numbers in CNY